Table 3.

Factors predicting remission of nephrotic syndrome after tacrolimus treatment in univariate and multivariate logistic model

Variables	Partial or complete remission			Complete remission
	OR	95% CI	P-Value	OR	95% CI	P-Value
Univariate logistic models
Gender (Female vs. Male)	1.6	0.99–2.6	0.06	3.1	1.9–4.9	<0.001
eGFR at baseline (for every 10 mL/min/1.73 m2)	1.1	1.0–1.2	0.003	1.1	1.0–1.2	0.06
Proteinuria at the onset of tacrolimus therapy	0.94	0.87–1.0	0.11	0.94	0.86–1.0	0.22
Previous treated with immunosuppressive drugs (Yes vs. No)	0.42	0.25–0.70	<0.001	0.42	0.19–0.85	0.02
Average tacrolimus exposure (ng/mL)	1.2	1.1–1.3	0.004	1.2	1.0–1.3	0.005
Multivariate logistic model
Gender (Female vs. Male)	1.7	1.0–3.0	0.04	3.3	2.0–5.6	<0.001
Previous treatment with immunosuppressive drugs (Yes vs. No)	0.39	0.22–0.67	<0.001	0.40	0.17–0.83	0.02
eGFR at baseline (for every 10 mL/min/1.73 m2)	1.2	1.1–1.4	0.001	1.1	0.99–1.2	0.07
Average tacrolimus exposure (ng/mL)	1.2	1.1–1.3	0.001	1.2	1.0–1.2	<0.001